Characterization of biomarkers for transfusion-related immunomodulatio
Recruiting
- Conditions
- transfusion-related immunomodulation
- Registration Number
- DRKS00031360
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Written consent
- any of the following medical treatments:
o above-knee amputation
o coronary artery bypass grafting (CABG)
o surgical transcatheter aortic valve implantation (TAVI)
o critical care (
Exclusion Criteria
- Pregnancy
- Sepsis (diagnosis within 3 days ahead of screening)
- leukemia
- Therapy with immune checkpoint inhibitors
- Inclusion in an interventional study
- Infectious viral diseases (HBV, HCV, HIV, COVID-19)
- Iatrogenic immunosuppression
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method